Prevention of transfusion-transmitted cytomegalovirus: Reactivation of the debate?

Transfusion

Volumn 47, Issue 11, 2007, Pages 1955-1958

  Drew, W L ^a   Roback, J D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; EDITORIAL; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LEUKOCYTE; MONOCYTE; PREVENTION; SCREENING; TORQUE TENO VIRUS; TRANSFUSION TRANSMITTED CYTOMEGALOVIRUS; VIRUS REPLICATION;

BLOOD TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; TISSUE DONORS;

EID: 35448971484     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01494.x     Document Type: Editorial

References (26)

1. Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion Transfusion 2007 47 : 1972 83.
2. Adler SP. Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983 5 : 977 93.
3. Adler SP, Baggett J, McVoy M. Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. Lancet 1985 2 : 743 7.
4. Ho M. Epidemiology of cytomegalovirus infection in man. In : Greenough WB, Merigan TC, editors. Cytomegalovirus biology and infection (current topics in infectious diseases). New York : Plenum 1982. p. 7 9 104.
5. Preiksaitis JK, Brown L, McKenzie M. The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression. J Infect Dis 1988 157 : 523 9.
6. Dworkin RJ, Drew WL, Miner RC, Mehalko S, Evans C, Baxter R. Survival of cytomegalovirus in viremic blood under blood bank storage conditions. J Infect Dis 1990 161 : 1310 1.
7. Reddehase MJ, Podlech J, Grzimek NK. Mouse models of cytomegalovirus latency: overview. J Clin Virol 2002 25 Suppl 2 : S23 36.
8. Sissons JG, Bain M, Wills MR. Latency and reactivation of human cytomegalovirus. J Infect 2002 44 : 73 7.
9. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999 180 : 702 7.
10. Slobedman B, Mocarski ES. Quantitative analysis of latent human cytomegalovirus. J Virol 1999 73 : 4806 12.
11. Lang DJ, Kummer JF. Demonstration of cytomegalovirus in semen. N Engl J Med 1972 287 : 756 8.
12. Jordan MC. Latent infection and the elusive cytomegalovirus. Rev Infect Dis 1983 5 : 205 15.
13. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995 86 : 3598 603.
14. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991 78 : 246 50.
15. Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, Meyers JD. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986 314 : 1006 10.
16. Miller WJ, McCullough J, Balfour HH Jr, Haake RJ, Ramsay NK, Goldman A, Bowman R, Kersey J. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991 7 : 227 34.
17. Winston DJ, Ho WG, Howell CL, Miller MJ, Mickey R, Martin WJ, Lin CH, Gale RP. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980 93 : 671 5.
18. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982 96 : 149 52.
19. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986 153 : 478 88.
20. Bowden R, Sayers M. The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion 1990 30 : 762 3.
21. Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, Slobedman B, Smith JW, Soderberg-Naucler C, Todd DS, Woxenius S, Busch MP. Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion 2001 41 : 1249 57.
22. Roback JD, Drew WL, Laycock ME, Todd D, Hillyer CD, Busch MP. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion 2003 43 : 314 21.
23. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M. Transfusion- transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003 101 : 4195 200.
24. Dumont LJ, Luka J, VandenBroeke T, Whitley P, Ambruso DR, Elfath MD. The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods. Blood 2001 97 : 3640 7.
25. Roback J, Buccolo L, Hillyer C. Effects of filtration and gamma-irradiation on cytomegalovirus (CMV) infectivity and replication: development of a rhesus macaque transfusion model. Blood 1997 90 (10 Suppl 3330.
26. Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion 2003 43 : 309 13.